SAVE - sleep apnea treatment: No cardiovascular benefit

August 29, 2016

More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea (OSA).

Findings from the Sleep Apnea Cardiovascular Endpoints (SAVE) study were presented at ESC Congress 2016, with simultaneous publication in the New England Journal of Medicine.

"Given the level of risk of attributed to OSA in previous observational studies, we were surprised not to find a benefit from CPAP treatment," said the study's principal investigator Doug McEvoy, MD, from the Adelaide Institute for Sleep Health at Flinders University in Adelaide, Australia.

The SAVE study recruited sleep apnea with moderate-to-severe disease from 89 clinical centres in 7 countries.

Participants were predominantly elderly (approximately 61 years), overweight, habitually snoring males - all with coronary artery or cerebrovascular disease.

A total of 2,717 individuals were randomized to receive usual care alone, or usual care plus CPAP.

To be eligible, participants had to achieve a minimum 3 hours of sham-CPAP adherence per night in a one week run-in before the study started.

Usual care included concomitant CV risk management, based on national guidelines, as well as advice on and lifestyle changes to minimize OSA.

The study showed that 42% of patients assigned to CPAP had good adherence (an average of 4 or more hours per night). Mean apnea-hypopnea index (AHI, a measure of OSA severity) decreased from 29.0 to 3.7 events per hour when patients used CPAP, indicating good control of their OSA.

However, after a mean follow-up time of 3.7 years for 1,341 usual care and 1,346 CPAP patients included in the final analysis, there was no difference between groups in the primary outcome - a composite of death from any CV cause, myocardial infarction or stroke, and hospitalisation for heart failure, acute coronary syndrome, or transient ischemic attack.

Specifically, 17.0% of patients in the CPAP group and 15.4% in usual-care had a serious CV event (hazard ratio 1.10; 95% CI 0.91 to 1.32; P=0.34).

"It's not clear why CPAP treatment did not improve CV outcomes," said Prof McEvoy.

"It is possible that, even though the average CPAP adherence of approximately 3.3 hours per night was as expected, and more than we estimated in our power calculations, it was still insufficient to show the hypothesized level of effect on CV outcomes."

Importantly though, CPAP did improve the wellbeing of participants, defined by symptoms of daytime sleepiness, health-related quality of life, mood - particularly depressive symptoms - and attendance at work.

Prof McEvoy said that "While it is disappointing not to find a reduction in CV events with CPAP treatment, our results show that treatment of OSA in patients with CV disease is nevertheless worthwhile - they are much less sleepy and depressed, and their productivity and quality of life is enhanced."

"More research is needed now on how to reduce the significant risk of CV events in people who suffer from ," he added.

"Given our finding of a possible reduction in cerebrovascular events in patients who were able to use CPAP for more than 4 hours per night, and of prior studies showing a stronger association between OSA and stroke than between OSA and coronary artery disease, future trials should consider targeting patients with OSA and stroke who can achieve a high level of compliance with CPAP."

Explore further: Researchers release global sleep apnoea study

Related Stories

Researchers release global sleep apnoea study

August 29, 2016
The largest sleep study ever undertaken has found that the leading therapy for obstructive sleep apnea (OSA), Continuous Positive Airway Pressure (CPAP), does not reduce recurrent strokes and heart attacks in people with ...

CPAP may not improve glycemic control in people with diabetes

March 11, 2016
People with type 2 diabetes and obstructive sleep apnea (OSA) may not experience improved glycemic control by using continuous positive airway pressure, or CPAP, as some studies have suggested, according to the results of ...

OSA increases cardiovascular mortality in the elderly

September 7, 2012
Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce ...

Study shows CPAP use for sleep apnea does not negatively impact sexual quality of life

October 21, 2014
Patients who use a continuous positive airway pressure (CPAP) device to treat obstructive sleep apnea (OSA) often believe that it makes them less sexually attractive, according to researchers at Rosalind Franklin University. ...

Income level doesn't substantially impact CPAP use

October 30, 2015
(HealthDay)—Among patients with severe obstructive sleep apnea (OSA), patient neighborhood income level is not significantly associated with purchase of continuous positive airway pressure (CPAP) device, and the overall ...

Recommended for you

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

Concerns that sleep apnea could impact healthspan

July 27, 2017
The number of people with obstructive sleep apnea has steadily increased over the past two decades. The disorder, which causes a person to briefly stop breathing when asleep, affects over 100 million people globally and is ...

Anti-nausea drug could help treat sleep apnea

June 6, 2017
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual ...

New disposable, wearable patch found to effectively detect sleep apnea

June 4, 2017
Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.